Wealthfront Advisers’s iShares US Medical Devices ETF IHI Stock Holding History

Wealthfront Advisers’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$557K	Buy	11,274 +689	+7%	+$35K	﹤0.01%	842
2026 Q1	$565K	Sell	10,585 -567	-5%	-$33.3K	﹤0.01%	812
2025 Q4	$693K	Buy	11,152 +1,052	+10%	+$64.9K	﹤0.01%	766
2025 Q3	$607K	Sell	10,100 -841	-8%	-$51.4K	﹤0.01%	784
2025 Q2	$685K	Sell	10,941 -925	-8%	-$55.6K	﹤0.01%	752
2025 Q1	$714K	Buy	11,866 +2,002	+20%	+$124K	﹤0.01%	719
2024 Q4	$576K	Sell	9,864 -265	-3%	-$15.7K	﹤0.01%	760
2024 Q3	$600K	Buy	10,129 +953	+10%	+$54.4K	﹤0.01%	740
2024 Q2	$514K	Sell	9,176 -44	-0.5%	-$2.46K	﹤0.01%	735
2024 Q1	$540K	Buy	9,220 +1,017	+12%	+$57.4K	﹤0.01%	724
2023 Q4	$443K	Sell	8,203 -2,473	-23%	-$121K	﹤0.01%	737
2023 Q3	$518K	Buy	10,676 +2,511	+31%	+$134K	﹤0.01%	680
2023 Q2	$461K	Sell	8,165 -1,289	-14%	-$71K	﹤0.01%	699
2023 Q1	$510K	Sell	9,454 -554	-6%	-$29.5K	﹤0.01%	656
2022 Q4	$526K	Buy	+10,008	New	+$508K	﹤0.01%	621
2022 Q3	–	Sell	-5,296	Closed	-$267K	–	772
2022 Q2	$267K	Sell	5,296 -3,727	-41%	-$203K	﹤0.01%	707
2022 Q1	$550K	Buy	9,023 +256	+3%	+$15.3K	﹤0.01%	614
2021 Q4	$577K	Buy	8,767 +1,045	+14%	+$66.9K	﹤0.01%	568
2021 Q3	$485K	Buy	+7,722	New	+$493K	﹤0.01%	563

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wealthfront Advisers's IHI Position: Q2 2026 in Review

Wealthfront Advisers increased its iShares US Medical Devices ETF (IHI) stake by 6.5% in Q2 2026, buying an estimated $35K and bringing the position to 11,274 shares worth $557K. The position accounts for ﹤0.01% of the portfolio, ranked #842.

Wealthfront Advisers first reported a position in IHI in Q3 2021 and has held it in 19 quarters since. The position peaked at $714K in Q1 2025. 501 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

Wealthfront Advisers held 11,274 shares of iShares US Medical Devices ETF worth $557K as of Q2 2026.
Wealthfront Advisers bought 689 iShares US Medical Devices ETF shares in Q2 2026, an estimated $35K.
iShares US Medical Devices ETF made up ﹤0.01% of Wealthfront Advisers's portfolio in Q2 2026, its #842 holding.
Wealthfront Advisers first reported a position in iShares US Medical Devices ETF in Q3 2021 and has held it in 19 quarters since.
Wealthfront Advisers's iShares US Medical Devices ETF position peaked at $714K in Q1 2025.
501 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Wealthfront Advisers's 13F filing for Q2 2026, filed 7 Aug 2026.